Login / Signup

On-label compared to off-label four-factor prothrombin complex concentrate use: a retrospective, observational study.

Brian C ChoYoun-Hoa JungVincent M DeMarioEdward LauStanley J PodlasekMichael C GrantEric A GehrieSteven M Frank
Published in: Transfusion (2019)
4F-PCC is an effective but expensive treatment option for those requiring urgent reversal of vitamin K antagonist-induced coagulopathy. However, providers should be conscious of the high costs and questionable efficacy when using 4F-PCC off-label.
Keyphrases
  • high glucose
  • diabetic rats
  • drug induced
  • endothelial cells